Gilead Sciences, Inc. (GILD)
128.15
-1.01
(-0.78%)
USD |
NASDAQ |
Jun 08, 16:00
128.00
-0.15
(-0.12%)
After-Hours: 17:25
Gilead Sciences Profit Margin (Quarterly) : 28.94% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biogen, Inc. | 13.29% |
| AbbVie, Inc. | 4.58% |
| Amgen, Inc. | 21.02% |
| Johnson & Johnson | 21.75% |
| Eli Lilly & Co. | 37.36% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 43.40% |
| Return on Assets | 16.11% |
| Return on Invested Capital | 20.15% |
| Gross Profit Margin (Quarterly) | 79.31% |
| Operating Margin (Quarterly) | 39.50% |
| Return on Net Operating Assets | 23.86% |